Literature DB >> 22445722

Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.

Mi Jin Lee1, Min-Yeong Woo, Yong-Joon Chwae, Myung-Hee Kwon, Kyongmin Kim, Sun Park.   

Abstract

TIM-3 is expressed by TH1 cells and negatively regulates cytokine production by these cells. The aim of the present study was to explore the mechanisms by which IL-2 production is suppressed in TIM-3-expressing T cells. First, the activity of two transcription factors that bind to the IL-2 promoter was examined in Jurkat T cells expressing TIM-3. Both AP-1 and NFAT activity were reduced in TIM-3-expressing cells stimulated with a phorbol ester and a calcium ionophore. At the same time, expression of the AP-1 components, c-Fos and c-Jun, was induced to a lesser extent in stimulated human primary CD4(+) T cells expressing high levels of TIM-3 than in those expressing low levels of TIM-3. Furthermore, TIM-3-expression inhibited the stimulation-induced dephosphorylation and nuclear translocation of NFAT in Jurkat T cells and primary CD4(+) T cells. Finally, the cytoplasmic tail of TIM-3 was required for the suppression of IL-2 production and for AP-1 and NFAT activation. Taken together, these results suggest that IL-2 production by T cells may be downregulated by TIM-3-mediated signals, leading to suppression of NFAT dephosphorylation and AP-1 transcription.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445722     DOI: 10.1016/j.imbio.2012.01.012

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases.

Authors:  Kiera L Clayton; Matthew S Haaland; Matthew B Douglas-Vail; Shariq Mujib; Glen M Chew; Lishomwa C Ndhlovu; Mario A Ostrowski
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

Review 2.  Tim-3 and its role in regulating anti-tumor immunity.

Authors:  Madhumita Das; Chen Zhu; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

3.  Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.

Authors:  Chris Y Chiu; Judy J Chang; Ashanti I Dantanarayana; Ajantha Solomon; Vanessa A Evans; Rachel Pascoe; Céline Gubser; Lydie Trautman; Rémi Fromentin; Nicolas Chomont; James H McMahon; Paul U Cameron; Thomas A Rasmussen; Sharon R Lewin
Journal:  J Immunol       Date:  2021-12-01       Impact factor: 5.422

4.  Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Authors:  Keiko Nagahara; Tomohiro Arikawa; Souichi Oomizu; Keiichi Kontani; Atsuya Nobumoto; Hiroaki Tateno; Kota Watanabe; Toshiro Niki; Shigeki Katoh; Minoru Miyake; Syun-Ichiro Nagahata; Jun Hirabayashi; Vijay K Kuchroo; Akira Yamauchi; Mitsuomi Hirashima
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 5.  Regulation of T cell responses by the receptor molecule Tim-3.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.

Authors:  Anne-Sophie Gautron; Margarita Dominguez-Villar; Marine de Marcken; David A Hafler
Journal:  Eur J Immunol       Date:  2014-06-16       Impact factor: 5.532

7.  T Cell Immunoglobulin Mucin Domain (TIM)-3 Promoter Activity in a Human Mast Cell Line.

Authors:  Jung Sik Kim; Dong-Chul Shin; Min-Yeong Woo; Myung-Hee Kwon; Kyongmin Kim; Sun Park
Journal:  Immune Netw       Date:  2012-10-31       Impact factor: 6.303

8.  TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.

Authors:  Brian Tomkowicz; Eileen Walsh; Adam Cotty; Raluca Verona; Nina Sabins; Fred Kaplan; Sandy Santulli-Marotto; Chen-Ni Chin; Jill Mooney; Russell B Lingham; Michael Naso; Timothy McCabe
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

9.  Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.

Authors:  Yong Xu; Zehua Wang; Xianhong Du; Yuan Liu; Xiaojia Song; Tixiao Wang; Siyu Tan; Xiaohong Liang; Lifen Gao; Chunhong Ma
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

10.  HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells.

Authors:  Jérémie Prévost; Cassandra R Edgar; Jonathan Richard; Steven M Trothen; Rajesh Abraham Jacob; Mitchell J Mumby; Suzanne Pickering; Mathieu Dubé; Daniel E Kaufmann; Frank Kirchhoff; Stuart J D Neil; Andrés Finzi; Jimmy D Dikeakos
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.